Friday 12 October 2001 - Afternoon
A The Health Professional: New Technologies,
Trends and Challenges - Anticipating Future Medical Practice
Evidence Based Medicine

13.00

 Welcome and Opening Remarks

J. Monsonego (France)

13.10

 Introduction: The Role of Evidence Based Medicine in Screening and Prevention of Cervical Cance

E. Franco (Canada)

13.30-15.30 - New Screening Strategies
Chair: C. Meijer (Netherlands), T. Wright (USA)

13.30

Liquid Based Cytology

J. Weintraub (Switzerland)

14.00

Early HPV Detection in Developed and Developing Countries

T. Wright (USA)

14.30

Real Time Screening Methods and Emerging Technologies

A. Singer (UK)

15.00

Expert Panel - Chair: R. Richart (USA), J.C. Boulanger (France)
Screening Protocols Relevant to Developed and Developing Countries:
Updated Strategies and Proposals
C. Clavel (France), D.Dachez (France), C. Meijer (Netherlands),
R. Sankaranaryanan (India), K. Syrjänen (Finland), L. Zerat (France)

16.00-18.30 - Management of Abnormal PAP - Current and Emerging Methods
Chair: A. Ferenczy (Canada), A. Singer (UK)

16.00

TBS revisited (TBS III)

R. Richart (USA)

16.20

HPV DNA Testing for Triage of Abnormal Pap

W. Kinney (USA)

16.40

The Role of Protein Markers

R. Richart (USA)

17.00

Colposcopy: Current Knowledge and Future Developments

S. Dexeus (Spain)

17.20

Conventional Methods of Treatment of CIN/GIN
and New Strategies for Determining Cure

A. Ferenczy (Canada)

17.40

Perspectives of Patient Applied Therapies for CIN
- Immunomodulators
- Retinoid Related Molecules

-P. Crowley-Nowick (USA)
M. Pfahl, Z. Dziewanowska (USA)

18.10

 Expert Panel - Chair: W. Kinney (USA), S. Dexeus (Spain)
Management of Abnormal PAP: Updated Strategies and Proposals
J.C. Boulanger (France), J.L. Mergui (France), D. Pereira Da Silva (Portugal),
K.U. Petry (Germany), J.L. Leroy (France)

Saturday 13 October 2001 - Morning

A The Health Professional: New Technologies,
Trends and Challenges Anticipating Future Medical Practice
Evidence Based Medicine (continued)
Chair: J. Goldberg (France)

8.15

Trends in Training and Continuing Medical Education

J. Jordan (UK)

8.30

Information Systems and Technology:
Opportunities and Challenges

To be determined

8.45-9.45 - Prevention of HPV Associated Lesions:
Rationale, Impact and Perspectives of HPV Vaccines
Chair. E. Franco (Canada), P. Coursaget (France).

8.45

Prophylactic & Therapeutic Vaccines: Recent
and Ongoing Studies

J. Schiller (USA)
9.20 Expert Panel
Prevention of HPV Associated Lesions:
Rationale, Impact and Perspectives of HPV Vaccines
L. Gissman(Germany), G. Orth (France),
 
B The Patient: An Advised Consumer
The Impact of Communication on Cervical Cancer Screening
 Chair: J. Patnick, NHS (UK), F. May-Levin, LCC (France)

10.15-12.15

10.15 Introduction: The Role of Women and Opinion Leaders
P. Judlin (France)

10.30

Patient Communication and Support Systems - The Internet

J. Austoker (UK)
Cancer Research Campain

10.50

The Impact of New Information Technologies:
E-Health: Patient Services and Free Access
to Quality Information

C. Boyer (Switzerland),
HON (Health On the Net
Foundation)

11.10

The Role of Public Opinion and Professional Lobbies

J. Godwin (UK)
Taylor Nelson Sofres

11.30

E-Health: Ethical and Legal Issues

S. Wallyn (Belgium)

11.50

 Discussion: Towards Customized Health Services

Saturday 13 October 2001 - Afternoon

C Studies on Health Economics and Mathematical Models
Chair: S. Goldie (USA), H. Sancho-Garnier (France)

13.45 - 15.30
13.45 Conventional Pap Smears
E. van den Akker-van Marle
(Netherlands)

14.00

HPV testing in Primary and Secondary Screening

S. Goldie (USA)

14.15

Liquid Based Cytology

M. Austin (USA)

14.30

Automation Technologies

P. Wertlake (USA)

14.45

Chemoprevention

P. Langley (USA),
G. Richwald (USA)
15.00

Vaccines

S. Goldie (USA)

D The Role of Health Care Decision Makers and Institutions
Chair: M. Friedman (USA), M. Parkin (France)

16.00 - 18.15

16.00

Introduction: Convergences and Divergences in
International Strategies in Cervical Cancer Screening

 J.Goldberg, ANAES (France)

16.15

The Role of Public-Private Partnerships

M. Friedman, NCI (USA)

16.45

The Consensus Conferences on Cervical
Cancer Screening and Management

 T. Wright (USA)
17.00 Cervical Cancer Screening: CDC and
the US Public STD Clinic Experience
G. Richwald (USA)

17.15

Global Evaluation of Contemporary Cervical
Cytology (AHCPR)

 E. Myers (USA)

17.30

The ALTS Trial Results (NIH)

 A. Ferenczy (Canada)

17.45

Impact of International Health Organizations

 M. Parkin (France)

18.00

Non-Governmental Organizations: Alliance for
Cervical Cancer Prevention, Gates Foundation

R. Sankaranarayanan (France/India)



Sunday 14 October 2001 - Morning

E Report from Sessions

8.15 - 9.45

8.15

New Screening Strategies

 C. Meijer (Netherlands)
T. Wright (USA)

8.30

Management of Abnormal PAP - Current and Emerging Methods

A. Ferenczy (Canada)
A. Singer (UK)

 

8.45

Prevention of HPV Associated Lesions: Rationale, Impact and Perspectives of HPV Vaccines

 J. Schiller (USA),
E. Franco (Canada)
P. Coursaget (France)

9.00

The Patient: An Advised Consumer - The Impact of
Communication on Cervical Cancer Screening

 J. Patnick (UK)
F. May-Levin (France)
9.15 Studies on Health Economics and Mathematical Models
S. Goldie (USA)
H. Sancho-Garnier (France)

9.30

The Role of Health Care Decision Makers and Institutions

M. Parkin (France)
M. Friedman, NCI (USA 
10.20 - 13.00
10.20 HPV Testing
X. Bosch (Spain)
W. Kinney (USA)
11.00 Liquid Based Cytology
M. Austin (USA)
11.40 Immunomodulators and Antiviral Drugs
P. Crowley-Nowick (USA)
12.20 Vaccines.
S. Goldie (USA)
K.U. Petry (Germany)